Curcumin nanodisk-induced apoptosis in mantle cell lymphoma

Leukemia and Lymphoma

Volumn 52, Issue 8, 2011, Pages 1537-1543

  Singh, Amareshwar T K ^a   Ghosh, Mistuni ^b   Forte, Trudy M ^c   Ryan, Robert O ^b,d   Gordon, Leo I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

apoptosis; cell cycle; curcumin; mantle cell lymphoma; Nanodisks

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CASPASE 9; CURCUMIN; CYCLIN D1; I KAPPA B ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYPHENOL; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P27; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHRL1;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; NANODISK; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL CYCLE; CELL LINE, TUMOR; CURCUMIN; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; G1 PHASE; HUMANS; LYMPHOMA, MANTLE-CELL; NANOSTRUCTURES; NANOTECHNOLOGY; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 79960406241     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.584253     Document Type: Article

References (32)

1. Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-2732 (Pubitemid 24317406)
2. Hartmann EM, Ott G, Rosenwald A. Molecular biology and genetics of lymphomas. Hematol Oncol Clin North Am 2008;22:807-823
3. Bertoni F, Ponzoni M. The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 2007;39:1747-1753 (Pubitemid 47321342)
4. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700-713 (Pubitemid 41058705)
5. Hussain AR, Ahmed M, Al-Jomah NA, et al. Curcumin suppresses constitutive activation of nuclear factor-KB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 2008;7:3318-3329
6. Tan TW, Tsai HR, Lu HF, et al. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation. Anticancer Res 2006;26:4361-4371
7. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa B alpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003;101:1053-1062 (Pubitemid 36139379)
8. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53- dependent Bax induction. FEBS Lett 2002;512:334-340 (Pubitemid 34164505)
9. Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3?-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 2007;30:905-918
10. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 2005;280:20059-20068 (Pubitemid 41379535)
11. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14:4491-4499
12. Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem 2007;102:580-592 (Pubitemid 47557413)
13. Ghosh M, Singh ATK, Sulchek T, Gordon LI, Ryan RO. Curcumin nanodisks: formulation and characterization. Nanomedicine 2011;7:162-167
14. Redmond KA, Nguyen T-S, Ryan RO. All-trans-retinoic acid nanodisks. Int J Pharm 2007;339:246-250 (Pubitemid 46977599)
15. Ryan RO. Nanodisks: hydrophobic drug delivery vehicles. Expert Opin Drug Deliv 2008;5:343-351 (Pubitemid 351454383)
16. Iovannisci DM, Beckstead JA, Ryan RO. Targeting nanodisks via a single chain variable antibody-apolipoprotein chimera. Biochem Biophys Res Commun 2009;379:466-469
17. Ryan RO, Forte TM, Oda MN. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003;27:98-103 (Pubitemid 37096475)
18. Singh AT, Evens AM, Anderson RJ, et al. All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. Br J Haematol 2010;150:158-169
19. Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007;13:789-794 (Pubitemid 46340350)
20. Kim SW, Oleksyn DW, Rossi RM, et al. Protein kinase C-associated kinase is required for NF-kB signaling and survival in diffuse large B-cell lymphoma cells. Blood 2008; 111:1644-1653 (Pubitemid 351213456)
21. Dijkers PF, Medema RH, Pals C, et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27 (KIP1). Mol Cell Biol 2000;20: 9138-9148 (Pubitemid 32246103)
22. Rummel MJ, de Vos S, Hoelzer D, et al. Altered apoptosis pathways in mantle cell lymphoma. Leuk Lymphoma 2004;45: 49-54 (Pubitemid 38181392)
23. Agarwal B, Naresh KN. Bcl-2 family of proteins in indolent Bcell non-Hodgkin's lymphoma: study of 116 cases. Am J Hematol 2002;70:278-282 (Pubitemid 34810504)
24. Rudelius M, Pittaluga S, Nishizuka S, et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 2006;108:1668-1676 (Pubitemid 44316136)
25. Lee DS, Lee MK, Kim JH. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res 2009;29:5039-5044
26. Uddin S, Hussain AR, Manogaran PS, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 2005;24:7022-7030 (Pubitemid 41573631)
27. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkBa by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-862 (Pubitemid 26106855)
28. Pérez-Galán P, Roué G, Villamor N, Montserrat E, Campo E, Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006;107:257-264 (Pubitemid 43053550)
29. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 2002;23:143-150 (Pubitemid 34213563)
30. Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 2005;280:25284-25290 (Pubitemid 40934623)
31. Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 2009;29:3867-3875
32. Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Res 2008;86: 300-310 (Pubitemid 351969628)